Hoffman: FTC won't accept pipeline divestitures in certain mergers
Credit: Freedom Film
The acting director of the Federal Trade Commission's bureau of competition has said that the commission will no longer accept the divestiture of pipeline products to remedy anticompetitive mergers in the inhalant and injectable drug industries.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10